申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04902719A1
公开(公告)日:1990-02-20
This invention relates to ornithine derivatives substituted at the 5 position with an R group which can be a --CH.sub.2 F, --CHF.sub.2, --CHClF, --C.tbd.CH, --CH.dbd.CH.sub.2, or --CH.dbd.C.dbd.CH.sub.2 group and the pharmaceutically acceptable acid addition salts thereof which are specific inhibitors of OAT and can be used in the treatment of conditional deficiencies of ornithine.
这项发明涉及在5位被R基取代的鸟氨酸衍生物,该R基可以是--CH.sub.2 F,--CHF.sub.2,--CHClF,--C.tbd.CH,--CH.dbd.CH.sub.2或--CH.dbd.C.dbd.CH.sub.2基团,以及它们的药用酸盐,它们是OAT的特异抑制剂,可用于治疗鸟氨酸条件性缺乏症。